3M Company reports recurring developments across its science-based industrial, transportation and electronics, and consumer businesses. Company updates commonly cover quarterly results, guidance, margins, cash flow, portfolio reshaping, transformation costs, PFAS and litigation-related items, and capital-structure activity.
News also includes product and capacity updates tied to 3M technologies and brands, including 3M Expanded Beam Optical interconnect solutions for data centers and Scotch-Brite consumer cleaning products. Other recurring themes include investor events, board and leadership appointments, government affairs, and manufacturing investments linked to the company's global operations.
3M, in collaboration with Discovery Education, has launched the Young Scientist Challenge Alumni Network and Alumni Grants Program. This initiative aims to support former participants of the Young Scientist Challenge by offering additional networking opportunities, resources, and funding for their scientific projects. The program will award $25,000 annually in grants to ten alumni, divided into three funding categories: $5,000 for project continuations, $2,500 for new ideas, and $1,000 for community science initiatives. Applications are open until March 23, 2023. This effort continues 3M's commitment to fostering future science leaders.
3M has addressed supply chain challenges by developing a process at its Springfield, Missouri plant to qualify alternate raw materials. Faced with supplier backorders in 2021, a multidisciplinary team explored options to substitute single-source materials. The initiative successfully updated over 1,500 products, reducing backorders by more than $5 million in just four months. This coordinated effort not only provides business continuity but also enhances supply chain flexibility and service to customers. Similar processes are being implemented in other 3M plants worldwide.
3M has announced its fourth-quarter 2022 earnings conference call scheduled for January 24, 2023, at 8 a.m. CST. Investors can join the call by dialing (800) 762-2596 within the U.S. or +1 (212) 231-2916 from abroad. The event will be accessible via live webcast, and a replay will be available on 3M's Investor Relations website. 3M continues to leverage science to innovate and address global challenges, showcasing its commitment to improving lives. For further information, visit 3M's Investor Relations page.
3M Health Information Systems and Edifecs have announced a collaboration to enhance the integration of technologies aimed at expediting the adoption of value-based payment models. This partnership combines 3M's healthcare payment methodologies with Edifecs' actuarial-driven templates to create a comprehensive solution for both payers and providers. Together, they aim to increase data transparency and improve patient outcomes by enabling advanced payment and accountability models. With nearly 60 years of combined experience, the solution addresses inefficiencies in the value-based care process.
3M showcased its innovative technologies at CES 2023, the world’s largest tech event. Key highlights include advancements in virtual reality with PICO VR headsets, collaboration on medical wearables such as the Gatorade Gx Sweat Patch with Epicore Biosystems, and contributions to the electric vehicle market with battery performance solutions. Additionally, 3M demonstrated the Post-it® App for Teams to support hybrid work.
Jayshree Seth, 3M's chief science advocate, participated in a panel on sustainability in consumer electronics.
3M is actively participating in a national initiative led by the White House to eliminate systemic barriers in STEMM (science, technology, engineering, mathematics, and medicine). This collaboration involves over 90 organizations and combines more than $1.2 billion in investments. As part of its commitment, 3M aims to provide 5 million STEMM learning experiences for underrepresented individuals by the end of the 2025-26 school year. This effort includes scholarships, fellowships, and initiatives to improve STEMM career awareness.
3M (NYSE: MMM) announced its decision to exit per- and polyfluoroalkyl substance (PFAS) manufacturing by the end of 2025, a move influenced by regulatory trends and stakeholder expectations. The company plans to discontinue the use of PFAS across its product portfolio, which currently generates approximately $1.3 billion in annual net sales. 3M expects to incur pre-tax charges between $1.3 billion and $2.3 billion during this transition, with about 70-80% being non-cash. This strategy aims to position 3M for sustainable growth while addressing environmental concerns.
3M is enhancing safety in 100 school zones across 23 countries by 2024, having completed 32 projects to date. These initiatives aim to protect 10,000 children, addressing the leading global cause of death for children due to road traffic accidents. A notable project in Japan improved visibility for students, prompting safer driver behavior. 3M collaborates with NGOs and local governments to implement high-performance road materials and technologies like Diamond Grade Reflective Sheeting for better visibility. The company emphasizes public-private partnerships to tackle road safety.
3M emphasizes the importance of maintaining clean indoor air, especially during the holiday season when homes are tightly sealed. Acknowledging that Americans spend 90% of their time indoors, the company outlines potential airborne pollutants, including allergens and microbes. It offers practical tips for improving indoor air quality, such as using air purifiers with True HEPA filters and ensuring HVAC systems are well-maintained. The press release highlights the availability of 3M's air quality products designed to enhance home environments.
Kindeva Drug Delivery and Meridian Medical Technologies have successfully merged, forming a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products. The newly combined entity, Kindeva, will leverage enhanced capabilities across various drug delivery methods, including inhalation and transdermal solutions. Milton Boyer, former CEO of Meridian, now leads Kindeva. This merger consolidates Kindeva's existing strength as a leader in drug-device solutions, having a rich history of innovation since the 1950s.